Objectives This study sought to characterize reasons for surgical ineligibility in patients undergoing nonemergent unprotected left main (ULM) percutaneous coronary intervention (PCI) and to assess the potential for these reasons to confound comparative effectiveness studies of coronary revascularization.
Observational comparisons of coronary artery bypass graft (CABG) surgical and percutaneous coronary intervention (PCI) treatment of unprotected left main (ULM) coronary disease are a burgeoning field in comparative effectiveness research (1, 2) . However, all observational comparisons are potentially limited by differences in baseline conditions that can affect the treatment choice and lead to treatment selection bias. If differences that bias treatment choice are not adjusted for and if they influence outcomes, then these unrecognized baseline conditions can significantly confound, and render inaccurate, such comparisons (3).
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Observational studies comparing modes of revascularization in left main disease have relied primarily on multivariable adjustment or the use of propensity scores to attempt to account for selection bias in the choice between CABG or PCI (4 -13) . However, these methods are limited in that they rely on measured variables (14) , which are typically traditional risk factors in studies of revascularization for ULM disease. This is especially true for studies using administrative or quality assessment data. As any clinician can attest, the factors that are considered in determining an individual patient's candidacy for CABG are often nuanced and not necessarily captured with standard procedural risk assessments (15) . Even though observational series of ULM PCI have provided insight into the prevalence of increased surgical risk and its impact on outcomes, most of these studies broadly characterized surgical risk or relied on traditionally measured risk factors or prediction scores (16 -29) . There is a paucity of data regarding factors that guide treatment choice in this population, and the potential for unmeasured factors to confound observational comparisons is unknown.
To address these gaps in knowledge, we sought to: 1) use clinical data to determine the prevalence of surgical ineligibility dictating treatment choice among patients undergoing nonemergent ULM PCI; 2) characterize the reasons cited for surgical ineligibility; 3) determine whether these reasons are captured by the ACC-NCDR (American College of Cardiology-National Cardiovascular Data Registry) Cath-PCI registry; and 4) determine whether surgical ineligibility is an independent predictor of outcomes and, therefore, a source of potential confounding in comparative effectiveness studies relying on ACC NCDR data.
Methods
Study population. This protocol was approved by the Institutional Review Board of Kaiser Permanente Northern California (KPNC) and a waiver of informed consent was granted. The study population included patients without a history of CABG who underwent PCI for ULM disease (defined as a noniatrogenic, de novo lesion with a diameter stenosis Ն50%) between January 2003 and December 2009 at Kaiser Permanente Medical Center, San Francisco. As the aim of the study was to assess determinants of treatment selection in a population of patients undergoing evaluation for either percutaneous or surgical revascularization, patients in whom clinical urgency resulted in emergent PCI were excluded, including those with cardiogenic shock, acute ST-segment elevation myocardial infarction, ongoing ischemic chest pain, or following cardiac arrest. Data abstraction and classification. Medical records were independently reviewed by 2 investigators (E.M. and W.N.) to classify patients by eligibility for CABG as judged by treating clinicians. The KPNC electronic medical record is robust and includes progress notes, operative reports, and discharge summaries, as well as all radiologic and clinical laboratory data and chronic problem lists. "CABG ineligible" was coded if the medical record contained documentation that the patient was not a candidate for CABG, or if the patient was referred for PCI after a surgical evaluation concluded that the patient's surgical risk was excessive. If the sole reason for choosing PCI was patient preference, the patient was coded as "CABG eligible," regardless of perceived risk. If there was no explicit documentation of the suitability of the patient for surgery, the patient was also coded as a "CABG eligible," regardless of perceived operative risk. The classification "CABG eligible" versus "CABG ineligible" was not an independent assessment of eligibility for CABG by the reviewer, but rather an assessment of documentation by the treating clinicians of each patient's eligibility for CABG. Interobserver agreement was assessed using the kappa statistic. In situations where the 2 investigators disagreed, consensus was achieved after discussion.
To systematically refine surgical ineligibility as the foundation for selecting PCI, reasons for ineligibility were extracted and grouped thematically to create a taxonomy. To mitigate ascertainment bias, the electronic medical records of all patients were again reviewed to determine the presence of any of the categorized reasons for surgical ineligibility in all patients including those classified as CABG-eligible.
Given the goal to assess the extent to which identified reasons for surgical ineligibility could be accounted for in comparative effectiveness research studies, we then established whether these reasons were captured by version 3 of the ACC-NCDR (American College of Cardiology National Cardiovascular Data Registry) Cath-PCI registry. This registry is a procedural registry used by over 1,000 U.S. hospitals as part of a quality assessment/improvement process and contains information on over 3 million patients undergoing PCI (30) . It is also being used (with version 3 data) for comparative effectiveness studies including the NIH-funded ASCERT (American College of Cardiology Foundation-Society of Thoracic Surgeons Collaboration on the Comparative Effectiveness of Revascularization Strategies) study comparing long-term outcomes of PCI and CABG (31) . Reasons cited for surgical ineligibility were therefore categorized as "Non-NCDR Captured" or "NCDR Captured."
Baseline characteristics, procedural variables, and discharge medications were compared for patients with and without documentation of surgical ineligibility. Over 130 variables were measured for each patient using definitions as stipulated by the NCDR, EuroSCORE (European System for Cardiac Operative Risk Evaluation), or Society of Thoracic Surgery scores where relevant (see Online Appendix 1 for list of variables extracted). Predicted mortalities were calculated using the logistic EuroSCORE (32), the Society of Thoracic Surgery Risk Score (33) , and the NCDR Cath-PCI risk score (34) . Statistical analyses. Continuous variables are presented as mean Ϯ SD or median (interquartile range). Categorical variables are presented as number (percentage). The Student t test or Wilcoxon rank-sum test were used to compare continuous variables as appropriate, and the chi-square or Fisher exact test were used to compare categorical variables. A 2-sided alpha of 0.05 was considered statistically significant.
Long-term clinical outcomes were then compared among all ULM PCI patients based on the presence or absence of surgical ineligibility. The primary outcome endpoint was all-cause mortality with secondary endpoints of: 1) combined death, any myocardial infarction, or permanent stroke; and 2) repeat revascularization (CABG or PCI). Time-to-event analysis was performed with patients considered at risk until the last documented physical encounter in the electronic medical record. The occurrence of outcomes was determined by manual chart review. The KPNC electronic medical record contains very detailed records regarding deaths, hospitalizations, and procedures, including those at hospitals outside of KPNC. Confirmation of vital status was performed via a query of the California automated mortality linkage system (35) . Survival curves were estimated by the Kaplan-Meier method, and outcomes of CABG-eligible patients were compared with outcomes of CABG-ineligible patients using the log-rank test.
Our sample size and the number of events precluded a full multivariable assessment of whether surgical ineligibility or the presence of any non-NCDR-measured risk factor were independent predictors of outcome. However, risk scores relying upon traditionally measured risk factors such as the EuroSCORE have been shown to predict long-term outcomes in patients undergoing surgical and percutaneous treatment of ULM disease (36, 37) . Therefore, we tested whether surgical ineligibility or the presence of any non-NCDR-measured risk factor remained independent predictors of outcomes when included as predictor variables along with predicted mortalities (as continuous covariates) from the EuroSCORE, STS model, and NCDR Cath-PCI mortality risk model in Cox proportional hazards models. Verification of the proportional hazards assumption was performed using the methods of Grambsch and Therneau (38) . Finally, given the long time interval of the study period, we tested whether there was an interaction with treatment year and surgical ineligibility. No temporal effect was observed.
Statistical analyses were performed using Stata version 11 (StataCorp, College Station, Texas).
Results
Study population. During the study period, 142 patients underwent ULM PCI. Thirty-eight were excluded for cardiogenic shock or ST-segment elevation myocardial infarction, and 3 were excluded for ongoing ischemic pain. The remaining 101 patients who underwent nonemergent PCI for ULM disease comprised the study cohort.
Classification of patients undergoing ULM PCI according to surgical eligibility. Explicit documentation of surgical ineligibility dictating the decision to perform ULM PCI was present in 55 of 101 patients. Initial interobserver agreement for this classification occurred in 92% of the patients, with a kappa statistic of 0.82 (indicative of very good agreement). At least 1 reason for surgical ineligibility was cited for each of the 55 patients and multiple reasons were common (Online Appendix 2). Reasons identified for CABG ineligibility are categorized in Figure 1 .
Comparison of CABG-eligible patients with CABG-ineligible
patients. Baseline characteristics, procedural variables, and discharge medications are compared between CABGineligible and CABG-eligible patients in Table 1 . CABGineligible patients had a greater prevalence of traditionally measured risk factors, including higher STS scores, NCDR Cath-PCI risk scores, and EuroSCOREs.
The prevalence of non-NCDR-captured clinical conditions in both groups is presented in Table 2 . At least 1 non-NCDR-captured condition was present in 78% of the CABG-ineligible patients and in 22% of those classified as CABG-eligible. We considered cachexia/frailty be a non-NCDR-measured risk factor. Although the NCDR measures height and weight, the mean body mass index of patients with cachexia/frailty was 24 Ϯ 9.4 kg/m 2 and within the normal range for all but 1 patient (range 19.6 to 26.7 kg/m 2 ). Association of surgical eligibility with clinical outcomes. The median follow-up until death or the last documented physical encounter was 540 days. One-year follow-up was available for 92% of the patients. There were 2 in-hospital deaths. In general, CABG-ineligible patients were more likely to die (hazard ratio [HR]: 7.7, 95% confidence interval [CI]: 1.8 to 33) or experience the combined endpoint of death, myocardial infarction, or stroke (HR: 3.0, 95% CI: 1.2 to 7.4) (Fig. 2) . There was no significant difference in repeat revascularizations for CABG-ineligible patients compared with CABG-eligible patients. Two patients underwent subsequent CABG (both were initially classified as CABG-eligible), and the remaining patients underwent repeat PCI (11 CABG-ineligible patients and 13 CABG-eligible patients). The presence of any non-NCDR-captured condition also predicted a markedly increased hazard of death on univariate analysis (HR: 5.3, 95% CI: 1.5 to 18) ( Table 3) . After adjusting for Euro-SCORE, STS score, or NCDR Cath-PCI mortality risk in Cox proportional hazards models, surgical ineligibility remained an independent predictor of mortality (HR: 5.4, 95% CI: 1.2 to 25 adjusted for STS score; HR: 5.9, 95% CI: 1.3 to 27 adjusted for EuroSCORE; HR: 6.2, 95% CI: 1.4 to 27 adjusted for NCDR risk model) ( Table 4 ). The presence of any non-NCDR-measured risk factor also remained an independent predictor of mortality after adjustment for the risk scores.
Discussion
Treatment selection bias and the potential for confounding by indication. Comparing the outcomes of alternative treatments in observational populations is challenging, primarily Values are mean Ϯ SD, n (%), or median (interquartile range). Comparison of patients with explicit documentation in the medical record of CABG ineligibility dictating decision to perform ULM PCI ("CABG ineligible") with those without documentation of surgical ineligibility ("CABG eligible").
Bold p values are statistically significant. *Probability Ͼ |Z| score Wilcoxon rank-sum test.
ACE ϭ angiotensin-converting enzyme; ARB ϭ angiotensin-receptor blocker; CABG ϭ coronary artery bypass graft; CHF ϭ congestive heart failure; EuroSCORE ϭ European System for Cardiac Operative Risk Evaluation; MI ϭ myocardial infarction; NCDR ϭ National Cardiovascular Data Registry; PCI ϭ percutaneous coronary intervention; STS ϭ Society of Thoracic Surgeons;
ULM ϭ unprotected left main. because treatment is not randomly assigned and there are often important clinical reasons for preferring 1 treatment over another. Our study exemplifies this problem in the context of nonemergent PCI for ULM disease. A careful review of clinical data revealed comorbid risk factors that dictated treatment selection in most patients. Patients who underwent ULM PCI because they were felt to be ineligible for surgery had a higher prevalence of traditionally measured risk factors including poor systolic function, acute presentations, and diabetes. However, they also had a higher prevalence of clinical conditions not measured by the ACC-NCDR Cath-PCI registry but felt to be important by treating physicians and surgeons. These included conditions that potentially complicate CABG, such as aortic calcification, as well as conditions associated with poor long-term prognosis, such as cancer and cachexia/frailty. Not surprisingly, the presence of these conditions was associated with markedly worse outcomes. Because these conditions are unmeasured by the ACC-NCDR Cath-PCI registry and are associated with worse outcomes, they would represent a significant source of potential confounding by indication in any study comparing modes of revascularization relying solely on ACC-NCDR data to adjust for differences in baseline conditions. Need to capture additional risk factors. Despite the common use of propensity scores to attenuate the impact of treatment selection bias in observational studies capturing only traditionally measured risk factors, there are limitations of such an approach (39,40). Our findings suggest that incorporating additional risk factors should be considered, Values are n (%). Prevalence of conditions not captured by the NCDR Cath-PCI registry in patients with or without explicit documentation in the medical record of surgical ineligibility dictating choice to perform ULM PCI. Bold p values are statistically significant.
Abbreviations as in Table 1 .
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S , V O L . 4 , N O . 9 , 2 0 1 1 S E P T E M B E R 2 0 1 1 : 1 0 2 0 -7
McNulty et al.
Selection Biases in Left Main Stenting
certainly for studies using clinical registries such as the NCDR Cath-PCI registry. As an example, studies of transcatheter aortic valve implantation are routinely collecting reasons for inoperability including frailty, aortic calcification, neoplasia, oxygen-dependent lung disease, and chest wall deformity (41, 42) . Other studies of CABG populations have demonstrated that "unconventional" risk factors such as hypoalbuminemia and prior mediastinal radiation adversely affect survival (43, 44) and should likewise be considered as predictor variables in observational studies.
Whereas conditions such as frailty may seem difficult to quantify, investigators have demonstrated that gait speed was a reliable surrogate for frailty and independently predicted outcomes (45) . Broader implications. Although we restricted our analysis to patients with ULM disease, it is likely that similar treatment selection bias occurs in patients with multivessel coronary disease without left main involvement. As PCI has emerged as an alternative therapy for patients who are not candidates for CABG, the impact of treatment selection bias should also be considered in studies of appropriate-use criteria relying on NCDR-derived data. Although prior studies using adjusted NCDR data have shown that patients undergoing PCI for indications rated as Class III in the American College of Cardiology/American Heart Association Guidelines have worse outcomes, the present analysis provides insight into why treatments might be chosen in apparent conflict with appropriate-use criteria or guidelines as a substantial proportion of patients treated with PCI likely lack a surgical alternative (46, 47) . Study limitations. The major strength of our study is its careful manual review of a comprehensive electronic medical record allowing capture of a large number of predictor variables. Nonetheless, important limitations need to be considered when interpreting our findings. First, our patient population comes from a single, large tertiary referral center and may not be generalizable. In addition, the lack of economic incentives in this staff-model integrated care organization, as well as CABG outcomes reporting being mandated by the state of California, might have had an impact on physician behavior. Our analysis is also inherently subjective and impossible to perform in a completely blinded fashion, despite stringent coding definitions and independent reviews. Moreover, even though medical records of all patients were reviewed a second time to minimize ascertainment bias, we relied on documentation in the medical record and did not prospectively collect these data using standardized definitions. Building upon this work, a supplement to the NCDR for ULM or multivessel PCI could theoretically overcome these limitations in future data collection efforts. Our sample size precluded full multivariable adjustment with all available NCDR data and it is possible that more complete adjustment might have attenuated the outcome differences we identified between CABG-eligible and -ineligible patients. However, there is Bold p values are statistically significant.
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Selection Biases in Left Main Stenting not much obvious correlation between the reasons we identified for treatment choice and NCDR data elements, and the observed effect sizes were large. Even though we adjusted for the EuroSCORE, STS score, and a risk score derived from the NCDR Cath-PCI registry, all of these models were developed to predict short-term mortality (up to 30 days in the NCDR model), and only the EuroSCORE has been previously shown to predict long-term mortality in patients undergoing ULM PCI (37) . Finally, we chose to use definitions from version 3 of the NCDR, as opposed to the currently in-use version 4, because data using the earlier version are being used in ongoing comparative effectiveness studies such as ASCERT. However, the "non-NCDRcaptured" variables identified in the present analysis are also not captured by version 4.
Conclusions
We found that most patients undergoing nonemergent ULM PCI are ineligible for CABG as an alternative. The reasons cited for ineligibility include conditions not captured by standard datasets, including by the largest national PCI registry. These unmeasured clinical conditions may represent a significant source of residual confounding for studies comparing modes of revascularization. Whereas registries such as ACC-NCDR Cath-PCI have served an invaluable role in assessing quality, caution in the use of these registries for comparative effectiveness studies is in order, and specific analyses need to be scrutinized to ensure that the observed differences in outcomes are not attributable to important but unmeasured clinical characteristics.
